Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Cancer Genet. 2017 Sep 14;218-219:39–50. doi: 10.1016/j.cancergen.2017.08.006

Table 3.

Concordance and discordance between the number of mutations detected in plasma and primary tumor DNA at the time of initial diagnosis

Primary tumor versus plasma at the time of diagnosis
Patient Disease Tumor tissue DNA mutations detected in plasma samples Plasma sample DNA mutations not detected in tumor tissues Cancer cells in tumor
1 colon AC 60% (3/5) 79% (11/14) 50%
2 colon AC 0% (0/5) 100% (5/5) 70%
3 colon AC 0% (0/1) 100% (13/13) 90%
4 colon AC 75% (3/4) 77% (10/13) 70%
5 colon AC 100% (3/3) 0% (0/3) 90%
average 47% 71.2% 74%
6 PDAC 25% (1/4) 92% (11/12) 30%
7 PDAC 33% (1/3) 89% (8/9) 40%
8 PDAC 33% (1/3) 86% (6/7) 50%
9 PDAC 0% (0/3) 100% (8/8) 50%
10 PDAC 50% (3/6) 25% (1/4) 40%
average 28.2% 78.4% 42%

AC= adenocarcinoma; PDAC= pancreatic ductal adenocarcinoma